OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pharmacogenetics of Antiplatelet Therapy
Matteo Castrichini, Jasmine A. Luzum, Naveen L. Pereira
The Annual Review of Pharmacology and Toxicology (2022) Vol. 63, Iss. 1, pp. 211-229
Open Access | Times Cited: 22
Matteo Castrichini, Jasmine A. Luzum, Naveen L. Pereira
The Annual Review of Pharmacology and Toxicology (2022) Vol. 63, Iss. 1, pp. 211-229
Open Access | Times Cited: 22
Showing 22 citing articles:
CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association
Naveen L. Pereira, Sharon Cresci, Dominick J. Angiolillo, et al.
Circulation (2024) Vol. 150, Iss. 6
Closed Access | Times Cited: 20
Naveen L. Pereira, Sharon Cresci, Dominick J. Angiolillo, et al.
Circulation (2024) Vol. 150, Iss. 6
Closed Access | Times Cited: 20
Platelet Distribution Width as a Marker for Severity and Extent of Coronary Artery Disease in Acute Coronary Syndrome
Fuat Polat, Zeynettin Kaya, Atakan Yanıkoğlu
International Journal of Cardiovascular Sciences (2025) Vol. 38
Open Access | Times Cited: 1
Fuat Polat, Zeynettin Kaya, Atakan Yanıkoğlu
International Journal of Cardiovascular Sciences (2025) Vol. 38
Open Access | Times Cited: 1
From genes to drugs: CYP2C19 and pharmacogenetics in clinical practice
Qamar Shubbar, Aminah Alchakee, Khaled Walid Issa, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Qamar Shubbar, Aminah Alchakee, Khaled Walid Issa, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Intersections and Challenges in the Management of Acute Coronary Syndrome and Stroke: Pathophysiology, Treatment Dilemmas, and Integrated Prevention Strategies
Maria Cristina Carella, Eugenio Carulli, Francesco Loizzi, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2354-2354
Open Access
Maria Cristina Carella, Eugenio Carulli, Francesco Loizzi, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2354-2354
Open Access
Pharmacogenetics ofP2Y12 receptor inhibitors
Cameron D. Thomas, Alexis K. Williams, Craig R. Lee, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2023) Vol. 43, Iss. 2, pp. 158-175
Open Access | Times Cited: 12
Cameron D. Thomas, Alexis K. Williams, Craig R. Lee, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2023) Vol. 43, Iss. 2, pp. 158-175
Open Access | Times Cited: 12
Recent advances in microfluidic technology of arterial thrombosis investigations
Jingying Lin, Si Chen, Chunying Zhang, et al.
Platelets (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 4
Jingying Lin, Si Chen, Chunying Zhang, et al.
Platelets (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 4
International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention
Dominick J. Angiolillo, Mattía Galli, Dimitrios Alexopoulos, et al.
КАРДИОЛОГИЯ УЗБЕКИСТАНА (2024) Vol. 17, Iss. 22, pp. 2639-2663
Closed Access | Times Cited: 4
Dominick J. Angiolillo, Mattía Galli, Dimitrios Alexopoulos, et al.
КАРДИОЛОГИЯ УЗБЕКИСТАНА (2024) Vol. 17, Iss. 22, pp. 2639-2663
Closed Access | Times Cited: 4
An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare Providers
Akinyemi Oni‐Orisan, Sony Tuteja, Glenda Hoffecker, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 114, Iss. 2, pp. 275-287
Open Access | Times Cited: 7
Akinyemi Oni‐Orisan, Sony Tuteja, Glenda Hoffecker, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 114, Iss. 2, pp. 275-287
Open Access | Times Cited: 7
Novel strategies in antithrombotic therapy: targeting thrombosis while preserving hemostasis
Martha M.S. Sim, Semekidus Shiferawe, Jeremy P. Wood
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 7
Martha M.S. Sim, Semekidus Shiferawe, Jeremy P. Wood
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 7
The Impact of CYP2C19 Genotype on the Platelet Reactivity Index (PRI) among Chronic Coronary Syndromes (CCS) Patients Undergoing Percutaneous Coronary Intervention (PCI): Affectability of Rapid Genetic Testing
Mohammed Ahmed Akkaif, Nur Aizati Athirah Daud, Dzul Azri Mohamed Noor, et al.
Cardiovascular Drugs and Therapy (2024)
Closed Access | Times Cited: 2
Mohammed Ahmed Akkaif, Nur Aizati Athirah Daud, Dzul Azri Mohamed Noor, et al.
Cardiovascular Drugs and Therapy (2024)
Closed Access | Times Cited: 2
Impact of CYP2C19 Genotype Status on Clinical Outcomes in Patients with Symptomatic Coronary Artery Disease, Stroke, and Peripheral Arterial Disease: A Systematic Review and Meta-Analysis
Dominique P.M.S.M. Maas, Loes H. Willems, Josephine Kranendonk, et al.
Drugs (2024) Vol. 84, Iss. 10, pp. 1275-1297
Open Access | Times Cited: 2
Dominique P.M.S.M. Maas, Loes H. Willems, Josephine Kranendonk, et al.
Drugs (2024) Vol. 84, Iss. 10, pp. 1275-1297
Open Access | Times Cited: 2
Pharmacogenomics of Cardiovascular Drugs for Atherothrombotic, Thromboembolic and Atherosclerotic Risk
Alfredo Mauriello, Antonia Ascrizzi, Riccardo Molinari, et al.
Genes (2023) Vol. 14, Iss. 11, pp. 2057-2057
Open Access | Times Cited: 2
Alfredo Mauriello, Antonia Ascrizzi, Riccardo Molinari, et al.
Genes (2023) Vol. 14, Iss. 11, pp. 2057-2057
Open Access | Times Cited: 2
Pharmacogenetic considerations in therapy with novel antiplatelet and anticoagulant agents
Anthony Yazbeck, Reem Akika, Zainab Awada, et al.
Pharmacogenetics and Genomics (2024)
Closed Access
Anthony Yazbeck, Reem Akika, Zainab Awada, et al.
Pharmacogenetics and Genomics (2024)
Closed Access
Identifying and Overcoming Clopidogrel Resistance: Where Do We Stand?
Mattía Galli, Naveen L. Pereira
Journal of Cardiovascular Pharmacology (2024) Vol. 84, Iss. 3, pp. 316-318
Open Access
Mattía Galli, Naveen L. Pereira
Journal of Cardiovascular Pharmacology (2024) Vol. 84, Iss. 3, pp. 316-318
Open Access
The polygenic implication of clopidogrel responsiveness: Insights from platelet reactivity analysis and next-generation sequencing
Omar Echeverría, Mariana Angulo-Aguado, Ricardo Vela, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0306445-e0306445
Open Access
Omar Echeverría, Mariana Angulo-Aguado, Ricardo Vela, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0306445-e0306445
Open Access
Cardiovascular Pharmacogenetics: From Discovery of Genetic Association to Clinical Adoption of Derived Test
Benoît Delabays, Katerina Trajanoska, Joshua Walonoski, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 5, pp. 791-827
Open Access
Benoît Delabays, Katerina Trajanoska, Joshua Walonoski, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 5, pp. 791-827
Open Access
The first in‐human study to evaluate the antiplatelet properties of the clopidogrel conjugate DT‐678 in acute coronary syndrome patients and healthy volunteers
Zhihao Liu, Shengcong Liu, Yanjun Gong, et al.
British Journal of Pharmacology (2024)
Open Access
Zhihao Liu, Shengcong Liu, Yanjun Gong, et al.
British Journal of Pharmacology (2024)
Open Access
Cost analysis of CYP2C19 genetic testing in percutaneous coronary intervention patients
Samuel B Huxley, James P. Moriarty, Mark A. Hlatky, et al.
The Pharmacogenomics Journal (2024) Vol. 24, Iss. 6
Closed Access
Samuel B Huxley, James P. Moriarty, Mark A. Hlatky, et al.
The Pharmacogenomics Journal (2024) Vol. 24, Iss. 6
Closed Access
Efficacy of P2Y12 receptor inhibitors in myocardial infarction in individuals carrying different CYP2C19 genotypes living in the northern region of Russia
A. S. Vorobyov, Г. И. Лифшиц, Е. М. Zelenskaya, et al.
Russian Journal of Cardiology (2024) Vol. 29, Iss. 10, pp. 5904-5904
Open Access
A. S. Vorobyov, Г. И. Лифшиц, Е. М. Zelenskaya, et al.
Russian Journal of Cardiology (2024) Vol. 29, Iss. 10, pp. 5904-5904
Open Access
Association of CYP2C19*2 c.681G>A (rs4244285) Loss-of-function Allele with Cardiovascular Disease Risk in the Kosovo Population
N Elshani, K Ukella, Stojovska M Staninova, et al.
Balkan Journal of Medical Genetics (2024) Vol. 27, Iss. 2, pp. 77-85
Open Access
N Elshani, K Ukella, Stojovska M Staninova, et al.
Balkan Journal of Medical Genetics (2024) Vol. 27, Iss. 2, pp. 77-85
Open Access
Genetics in the diagnosis and treatment of cardiovascular diseases
Kevin P. Bliden, Sahib Singh, Roni Shanoada, et al.
Journal of Translational Genetics and Genomics (2024) Vol. 8, Iss. 2, pp. 186-206
Open Access
Kevin P. Bliden, Sahib Singh, Roni Shanoada, et al.
Journal of Translational Genetics and Genomics (2024) Vol. 8, Iss. 2, pp. 186-206
Open Access
Sequence‐Guided Localization of DNA Hybridization Enables Highly Selective and Robust Genotyping
Xuchu Wang, Tao Chen, Ping Ying, et al.
Small (2023) Vol. 20, Iss. 20
Closed Access
Xuchu Wang, Tao Chen, Ping Ying, et al.
Small (2023) Vol. 20, Iss. 20
Closed Access
